CAR-T药进入商保创新药目录,五款百万级别产品成大赢家

第一财经
Yesterday

过往,CAR-T这种百万级别的细胞治疗药物,始终无缘走到国家医保目录谈判桌上。如今,这些药物在商保方面的支付迎来突破。   12月7日,在2025创新药高质量发展大会上,首版《商业健康保险创新药品目录》正式公布,共有5款CAR-T细胞药物成功进入目录,分别是复星凯瑞的阿基仑赛注射液、药明巨诺的瑞基奥仑赛注射液、合源生物的纳基奥仑赛注射液、驯鹿生物的伊基奥仑赛注射液、科济药业的泽沃基奥仑赛注射液。 ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10